04:25 PM EDT, 06/11/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on June 11, 2024, sold 7,788 shares in Cytokinetics ( CYTK ) for $413,106. Following the Form 4 filing with the SEC, Malik has control over a total of 135,004 shares of the company, with 135,004 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000112760224018365/xslF345X03/form4.xml
Price: 53.08, Change: -0.21, Percent Change: -0.39